Hengrui Medicine (01276): SHR-7590 Injection has obtained the notification for approval of clinical drug trials.

Zhongan Finance APP reported that Heng Rui Medicine (01276) announced that its subsidiary, Guangdong Heng Rui Medicine Co., Ltd., has received the Drug Clinical Trial Approval Notification issued by the National Medical Products Administration for SHR-7590 injection, and will soon commence clinical trials.